Literature DB >> 2497174

Induction of class II MHC antigen expression in macrophages by Mycoplasma species.

P M Stuart1, G H Cassell, J G Woodward.   

Abstract

Several different Mycoplasma species have been shown to act as mitogens for either T or B cells and as stimulators of macrophage tumoricidal activity. In this report, we show that at least five different species of Mycoplasma are capable of inducing class II MHC expression on macrophages. We have observed significant induction of class II MHC surface expression on the myelomonocytic cell line, WEHI-3, as early as 24 h after deliberate infection of cultures, reaching maximal levels by 4 days. This induction was also apparent at the mRNA level as assessed by Northern blot analysis by using A alpha, E alpha, and A beta probes. However, unlike many other previously described MHC-inducing agents, mycoplasmas failed to induce class I MHC expression at either the cell surface or mRNA levels. Kinetic analysis revealed that induction of class II mRNA by mycoplasmas was slower than induction by IFN-gamma requiring 24 h rather than 8 h for significant increases to be noted. Induction by mycoplasmas does not require the presence of live organisms and remains active after heat treatment of 90 degrees C for 30 min. We have also demonstrated that mycoplasma infection of primary bone marrow macrophage cultures leads to the induction of both class I and class II genes and, as in the case of WEHI-3, this induction does not require the presence of live organisms. These data indicate that several Mycoplasma species have the capacity to induce class II MHC expression in WEHI-3 and both class I and class II MHC expression in bone marrow macrophage cultures in the absence of any T cell products.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2497174

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

1.  Mycoplasma pulmonis possesses a novel chemoattractant for B lymphocytes.

Authors:  S E Ross; J W Simecka; G P Gambill; J K Davis; G H Cassell
Journal:  Infect Immun       Date:  1992-02       Impact factor: 3.441

2.  Genotypic and phenotypic analysis of Mycoplasma fermentans strains isolated from different host tissues.

Authors:  L Campo; P Larocque; T La Malfa; W D Blackburn; H L Watson
Journal:  J Clin Microbiol       Date:  1998-05       Impact factor: 5.948

3.  Differential induction of bone marrow macrophage proliferation by mycoplasmas involves granulocyte-macrophage colony-stimulating factor.

Authors:  P M Stuart; G H Cassell; J G Woodward
Journal:  Infect Immun       Date:  1990-11       Impact factor: 3.441

4.  Membrane-associated nuclease activities in mycoplasmas.

Authors:  F C Minion; K J Jarvill-Taylor; D E Billings; E Tigges
Journal:  J Bacteriol       Date:  1993-12       Impact factor: 3.490

5.  Interaction of Mycoplasma dispar with bovine alveolar macrophages.

Authors:  R A Almeida; M J Wannemuehler; R F Rosenbusch
Journal:  Infect Immun       Date:  1992-07       Impact factor: 3.441

6.  Mycoplasma hyorhinis molecules that induce tumor necrosis factor alpha secretion by human monocytes.

Authors:  D A Kostyal; G H Butler; D H Beezhold
Journal:  Infect Immun       Date:  1995-10       Impact factor: 3.441

Review 7.  Molecular biology and pathogenicity of mycoplasmas.

Authors:  S Razin; D Yogev; Y Naot
Journal:  Microbiol Mol Biol Rev       Date:  1998-12       Impact factor: 11.056

8.  Purification and partial biochemical characterization of a Mycoplasma fermentans-derived substance that activates macrophages to release nitric oxide, tumor necrosis factor, and interleukin-6.

Authors:  P F Mühlradt; M Frisch
Journal:  Infect Immun       Date:  1994-09       Impact factor: 3.441

9.  Activation of murine macrophages and lymphocytes by Ureaplasma diversum.

Authors:  A Chelmonska-Soyta; R B Miller; L Ruhnke; S Rosendal
Journal:  Can J Vet Res       Date:  1994-10       Impact factor: 1.310

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.